Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10172898

Biomedical warfare.

M W Serafini
View original source ↗Export metadata ↓

Abstract

A bruising battle for scarce research dollars is being waged among competing advocacy groups that seek cures for dread diseases. Many activists are unwilling to leave decisions to the scientists. They want Congress to decide which diseases deserve the most bucks.

Explore related subjects

Acquired Immunodeficiency SyndromeAlzheimer DiseaseBreast NeoplasmsDiabetes MellitusHealth PrioritiesHeart DiseasesHumansNational Institutes of Health (U.S.)Parkinson DiseasePatient AdvocacyPoliticsResearch Support as TopicUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M W Serafini. 1997-02-01. Biomedical warfare.. https://pubmed.ncbi.nlm.nih.gov/10172898/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Estimating HIV incidence using dates of both HIV and AIDS diagnoses.

Knowledge of HIV incidence is important to formulate sensible strategies aimed at controlling the HIV/AIDS epidemic. Back-projection is one of the methods for reconstructing the HIV incidence curve from AIDS incidence data. However, because of the low risk of developing AIDS during the first few years after infection, precise estimates of HIV incidence for the recent past are unlikely if we use AIDS incidence data only. As a result there have been recent attempts to use, not only the date of AIDS diagnosis, but also to use the date of their first positive HIV test. The objective of this paper is to incorporate into back-projection the additional information provided by those individuals who have tested HIV positive but have not yet developed AIDS. This adds information on a very large number of other individuals, and provides the hope that the precision of back-projection is improved considerably. The date of a positive HIV test or an AIDS diagnosis of an individual, whichever comes first, is used in a generalized convolution equation for the purpose of back-projection. The method is illustrated by an application to Australian HIV and AIDS data. Study results show that dramatic improvement in precision is gained for estimates of HIV incidence in recent years when both HIV and AIDS diagnosis dates are used on all individuals.

Acquired Immunodeficiency Syndrome↗
PubMed2000

Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome.

Highly-active antiretroviral therapy (HAART) has lead to a dramatic decrease in the morbidity of patients infected with the human immunodeficiency virus (HIV). However, metabolic side effects, including lipodystrophy-associated (LD-associated) dyslipidemia, have been reported in patients treated with antiretroviral therapy. This study was designed to determine whether successful HAART was responsible for a dysregulation in the homeostasis of tumor necrosis factor-alpha (TNF-alpha), a cytokine involved in lipid metabolism. Cytokine production was assessed at the single cell level by flow cytometry after a short-term stimulation of peripheral blood T cells from HIV-infected (HIV(+)) patients who were followed during 18 months of HAART. A dramatic polarization to TNF-alpha synthesis of both CD4 and CD8 T cells was observed in all patients. Because it was previously shown that TNF-alpha synthesis by T cells was highly controlled by apoptosis, concomitant synthesis of TNF-alpha and priming for apoptosis were also analyzed. The accumulation of T cells primed for TNF-alpha synthesis is related to their escape from activation-induced apoptosis, partly due to the cosynthesis of interleukin-2 (IL-2) and TNF-alpha. Interestingly, we observed that LD is associated with a more dramatic TNF-alpha dysregulation, and positive correlations were found between the absolute number of TNF-alpha CD8 T-cell precursors and lipid parameters usually altered in LD including cholesterol, triglycerides, and the atherogenic ratio apolipoprotein B (apoB)/apoA1. Observations from the study indicate that HAART dysregulates homeostasis of TNF-alpha synthesis and suggest that this proinflammatory response induced by efficient antiretroviral therapy is a risk factor of LD development in HIV(+) patients.

Acquired Immunodeficiency Syndrome↗